Cardiology Practice 2004 -- Standardized Treatment

Author: Hu Dayi
Publisher:
Publish Date: 2005-01-01
Features: The American College of Cardiology proposed evidence-based guidelines for the prevention and treatment of cardiovascular diseases in women in 2004; revised the target for lipid reduction in high-risk populations, recommending that low-density lipoprotein cholesterol in very high-risk coronary heart disease patients be reduced to below 70 mg/dL; revised the guidelines for acute ST-segment elevation myocardial infarction, indicating that reperfusion therapy should be determined based on the time of onset and the risk of treatment. The validation of new concepts and the development and application of new technologies have brought revolutionary changes to cardiology practice. The introduction of drug-eluting stents has had a profound impact on the treatment strategy for coronary artery revascularization; the increasing maturity of catheter ablation for atrial fibrillation has significantly improved ablation success rates; the important role of intensive lipid-lowering therapy in preventing coronary heart disease and reducing cardiac events has been consistently confirmed in all relevant clinical trials; the exploration of stem cells in clinical applications has opened up new avenues for treating heart failure.